\
&
Contact us
Biodiversa+ is the European Biodiversity Partnership that supports excellent research on biodiversity with an impact on policy and society. Biodiversa+ is working towards the 2050 vision of “living in harmony with nature,” in line with global biodiversity goals and the EU Biodiversity Strategy for 2030.
The partnership aims to halt ecosystem loss by 2030, reduce species extinction risks, and support the recovery of biodiversity across Europe.
A major focus is on scaling up nature-based solutions to address societal challenges while strengthening the role of biodiversity in sustainable development and the green economy.
To deliver impact, Biodiversa+ has identified five strategic objectives, including improving biodiversity monitoring, generating actionable knowledge, and supporting evidence-based policymaking. It also promotes science-based approaches to valuing ecosystem services and natural capital, helping integrate biodiversity into broader decision-making.
These ambitions are implemented through nine interconnected work packages covering research and innovation, monitoring, policy support, international cooperation, and stakeholder engagement. Communication, open science, and coordination are also central to ensuring that Biodiversa+ activities remain aligned and effective.
Together, these efforts are designed to drive transformative change and put biodiversity on a path to recovery in Europe and beyond.
Contact
BiodivERsA: https://www.biodiversa.eu/contact/
FWO: Toon Monbaliu
Belspo: Aline Van der Werf
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
pascal.verheye@vlaio.be
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.